Photo by nci from unsplash
e13065Background: Recently developed microtubule dynamics inhibitor eribulin mesylate (eribulin) differs from taxanes and vinca alkaloids by another mechanism of action. Here, we describe eribulin-... Click to show full abstract
e13065Background: Recently developed microtubule dynamics inhibitor eribulin mesylate (eribulin) differs from taxanes and vinca alkaloids by another mechanism of action. Here, we describe eribulin-...
Keywords:
long term;
breast cancer;
term responders;
metastatic breast;
responders metastatic;
eribulin
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!